Second-site NMR screening and linker design

Wolfgang Jahnke1, Andreas Flörsheimer, Marcel J J Blommers

  • 1Novartis Pharma AG, Central Technologies and Oncology Research, CH-4002 Basel, Switzerland. wolfgang.jahnke@pharma.novartis.com

Related Concept Videos